Show
Sort by
-
- Journal Article
- A1
- open access
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting : a randomized placebo-controlled phase II trial
-
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma
-
Aspergillus fumigatus recognition by dendritic cells negatively regulates allergic lung inflammation through a TLR2/MyD88 pathway
-
- Journal Article
- A1
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
-
The global response to the COVID-19 pandemic : how have immunology societies contributed?
-
Inflammatory properties and adjuvant potential of synthetic glycolipids homologous to mycolate esters of the cell wall of Mycobacterium tuberculosis
-
Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice